Nuzenio

Fda Breakthrough Therapy

Fda Breakthrough Therapy news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 14 publisher sources 100/100 entity strength

Latest news

The OncFive: Top Oncology Articles for the Week of 8/2 - OncLiveOncLive · Sat, 08 Aug 2026 10:13:24 GMT FDA Grants Breakthrough Therapy Status to a Pancreatic Cancer Drug for a Mutation Found in Roughly 1 in 50 Patients - Medical DailyMedical Daily · Thu, 06 Aug 2026 12:50:07 GMT FDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer - OncodailyOncodaily · Wed, 05 Aug 2026 13:26:29 GMT FDA grants breakthrough therapy designation to Lilly’s olomorasib - Pharmaceutical Business review -Pharmaceutical Business review - · Tue, 04 Aug 2026 19:15:28 GMT Olomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 15:38:44 GMT Lilly’s olomorasib gets FDA Breakthrough Therapy designation for pancreatic cancer - PMLiVEPMLiVE · Tue, 04 Aug 2026 10:55:00 GMT Eli Lilly (LLY) Wins FDA Breakthrough Tag For Olomorasib, Backs $70 Million Raise - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 21:08:39 GMT FDA Grants Breakthrough Status to Olomorasib in Pancreatic Cancer - Targeted OncologyTargeted Oncology · Mon, 03 Aug 2026 20:07:34 GMT

Timeline

Sat, 08 Aug 2026 10:13:24 GMTThe OncFive: Top Oncology Articles for the Week of 8/2 - OncLive

Thu, 06 Aug 2026 12:50:07 GMTFDA Grants Breakthrough Therapy Status to a Pancreatic Cancer Drug for a Mutation Found in Roughly 1 in 50 Patients - Medical Daily

Wed, 05 Aug 2026 13:26:29 GMTFDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer - Oncodaily

Tue, 04 Aug 2026 19:15:28 GMTFDA grants breakthrough therapy designation to Lilly’s olomorasib - Pharmaceutical Business review -

Tue, 04 Aug 2026 15:38:44 GMTOlomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer - CancerNetwork

Tue, 04 Aug 2026 10:55:00 GMTLilly’s olomorasib gets FDA Breakthrough Therapy designation for pancreatic cancer - PMLiVE

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Lilly10 live mentions KRAS8 live mentions Olomorasib6 live mentions FDA6 live mentions LLY4 live mentions FDA Breakthrough Designation4 live mentions FDA Grants Breakthrough3 live mentions Therapy Designation3 live mentions Pharmaceutical Business3 live mentions Breakthrough Therapy3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Fda Breakthrough Therapy.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.